Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies

Rare cases of COVID‐19 vaccinated individuals develop anti‐platelet factor 4 (PF4) antibodies that cause thrombocytopenia and thrombotic complications, a syndrome referred to as vaccine‐induced immune thrombotic thrombocytopenia (VITT). Currently, information on the characteristics and persistence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanack, Adam J., Singh, Bandana, George, Gemlyn, Gundabolu, Krishna, Koepsell, Scott A., Abou‐Ismail, Mouhamed Yazan, Moser, Karen A., Smock, Kristi J., Green, David, Major, Ajay, Chan, Clarence W., Wool, Geoffrey D., Reding, Mark, Ashrani, Aneel A., Bayas, Antonios, Grill, Diane E., Padmanabhan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986571/
https://www.ncbi.nlm.nih.gov/pubmed/35132672
http://dx.doi.org/10.1002/ajh.26488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986571/
https://www.ncbi.nlm.nih.gov/pubmed/35132672
http://dx.doi.org/10.1002/ajh.26488

Ejemplares similares